JPMorgan Chase & Co. Issues Pessimistic Forecast for Cabot (NYSE:CBT) Stock Price

Cabot (NYSE:CBT) had its target price cut by research analysts at JPMorgan Chase & Co. from $75.00 to $54.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s target price would suggest a potential downside of 13.85% from the stock’s previous close.

CBT has been the subject of a number of other reports. Mizuho decreased their price objective on Cabot from $78.00 to $72.00 and set an “outperform” rating for the company in a report on Monday, November 17th. Zacks Research cut shares of Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Finally, UBS Group reduced their target price on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Cabot has an average rating of “Reduce” and a consensus price target of $63.67.

Cabot Stock Performance

Shares of NYSE CBT opened at $62.69 on Friday. The business has a fifty day simple moving average of $68.02 and a 200 day simple moving average of $73.93. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66. Cabot has a one year low of $58.33 and a one year high of $115.16. The firm has a market capitalization of $3.32 billion, a price-to-earnings ratio of 8.19 and a beta of 0.90.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The company had revenue of $899.00 million for the quarter, compared to analyst estimates of $967.02 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The company’s revenue was down 10.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Sell-side analysts expect that Cabot will post 7.57 EPS for the current year.

Institutional Trading of Cabot

Several institutional investors and hedge funds have recently bought and sold shares of the business. Smartleaf Asset Management LLC boosted its stake in shares of Cabot by 598.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 299 shares during the period. Elevation Point Wealth Partners LLC acquired a new stake in Cabot during the 2nd quarter valued at $28,000. Parkside Financial Bank & Trust boosted its position in Cabot by 95.5% during the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 189 shares during the period. Hantz Financial Services Inc. increased its holdings in shares of Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 298 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.